SCHEMBL5075002

SCHEMBL5075002

[CH2]CCCCCCCCCOCC(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.42
CYP2C19 P33261 1/20 0.41
EPHX2 P34913 1/20 0.39
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
ALDH1A1 P00352 2/20 0.35
PLA2G4B P0C869 3/20 0.34
TSHR P16473 4/20 0.33
CTH P32929 1/20 0.33
CBS P35520 1/20 0.33
THPO P40225 1/20 0.33
CYP3A4 P08684 1/20 0.32
THRB P10828 1/20 0.32
TBXA2R P21731 3/20 0.32
PAM P19021 2/20 0.31
NR1I2 O75469 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
DRD1 P21728 1/20 0.31
AGTR1 P30556 1/20 0.31
PTGIR P43119 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9123930 1.00 CES2 (0.42) CES2CYP2C19EPHX2CYP4F2CYP4A11
SCHEMBL9122483 0.98 EPHX2 (0.40) CES2CYP2C19EPHX2CYP4F2CYP4A11
SCHEMBL8694378 0.91
SCHEMBL18660231 0.88 CES2 (0.50) CES2CYP2C19EPHX2CYP4F2CYP4A11
SCHEMBL7713583 0.88 CES2 (0.50) CES2CYP2C19EPHX2CYP4F2CYP4A11
SCHEMBL22922164 0.85 CES2 (0.48) CES2CYP2C19EPHX2CYP4F2CYP4A11
SCHEMBL10001230 0.85 CES2 (0.46) CES2CYP2C19EPHX2CYP4F2CYP4A11
SCHEMBL23405393 0.83 CES2 (0.46) CES2CYP2C19EPHX2CYP4F2CYP4A11
SCHEMBL20535086 0.83 CES2 (0.46) CES2CYP2C19EPHX2CYP4F2CYP4A11
SCHEMBL22922080 0.83 CES2 (0.44) CES2CYP2C19EPHX2CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1091745-B1 TREATMENT OF HYPERPROLIFERATIVE DISORDERS CHILDREN S HOSPITAL LOS ANGELE (US) 2008-10-01 EP claimed